115 related articles for article (PubMed ID: 31630195)
1. BRCA1 mislocalization leads to aberrant DNA damage response in heterozygous ABRAXAS1 mutation carrier cells.
Bose M; Sachsenweger J; Laurila N; Parplys AC; Willmann J; Jungwirth J; Groth M; Rapakko K; Nieminen P; Friedl TWP; Heiserich L; Meyer F; Tuppurainen H; Peltoketo H; Nevanlinna H; Pylkäs K; Borgmann K; Wiesmüller L; Winqvist R; Pospiech H
Hum Mol Genet; 2019 Dec; 28(24):4148-4160. PubMed ID: 31630195
[TBL] [Abstract][Full Text] [Related]
2. ABRAXAS1 orchestrates BRCA1 activities to counter genome destabilizing repair pathways-lessons from breast cancer patients.
Sachsenweger J; Jansche R; Merk T; Heitmeir B; Deniz M; Faust U; Roggia C; Tzschach A; Schroeder C; Riess A; Pospiech H; Peltoketo H; Pylkäs K; Winqvist R; Wiesmüller L
Cell Death Dis; 2023 May; 14(5):328. PubMed ID: 37198153
[TBL] [Abstract][Full Text] [Related]
3. Heterozygous PALB2 c.1592delT mutation channels DNA double-strand break repair into error-prone pathways in breast cancer patients.
Obermeier K; Sachsenweger J; Friedl TW; Pospiech H; Winqvist R; Wiesmüller L
Oncogene; 2016 Jul; 35(29):3796-806. PubMed ID: 26640152
[TBL] [Abstract][Full Text] [Related]
4. Repair versus Checkpoint Functions of BRCA1 Are Differentially Regulated by Site of Chromatin Binding.
Goldstein M; Kastan MB
Cancer Res; 2015 Jul; 75(13):2699-707. PubMed ID: 25939603
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functions.
Solyom S; Aressy B; Pylkäs K; Patterson-Fortin J; Hartikainen JM; Kallioniemi A; Kauppila S; Nikkilä J; Kosma VM; Mannermaa A; Greenberg RA; Winqvist R
Sci Transl Med; 2012 Feb; 4(122):122ra23. PubMed ID: 22357538
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of the BRCT tandem domains of nibrin by the 657del5 mutation affects the DNA damage response less than the Arg215Trp mutation.
Mendez G; Cilli D; Berardinelli F; Viganotti M; Ascenzi P; Tanzarella C; Antoccia A; di Masi A
IUBMB Life; 2012 Oct; 64(10):853-61. PubMed ID: 22941933
[TBL] [Abstract][Full Text] [Related]
7. Searching for new breast cancer-associated genes. ABRAXAS1 gene mutations in the group of BRCA1-negative patients.
Bąk A; Junkiert-Czarnecka A; Heise M; Januchowska D; Krzywińska O; Haus O
Pol J Pathol; 2018; 69(4):342-346. PubMed ID: 30786683
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 and CtIP Are Both Required to Recruit Dna2 at Double-Strand Breaks in Homologous Recombination.
Hoa NN; Kobayashi J; Omura M; Hirakawa M; Yang SH; Komatsu K; Paull TT; Takeda S; Sasanuma H
PLoS One; 2015; 10(4):e0124495. PubMed ID: 25909997
[TBL] [Abstract][Full Text] [Related]
9. Functional variant analyses (FVAs) predict pathogenicity in the BRCA1 DNA double-strand break repair pathway.
Loke J; Pearlman A; Upadhyay K; Tesfa L; Shao Y; Ostrer H
Hum Mol Genet; 2015 Jun; 24(11):3030-7. PubMed ID: 25652403
[TBL] [Abstract][Full Text] [Related]
10. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.
Cortez D; Wang Y; Qin J; Elledge SJ
Science; 1999 Nov; 286(5442):1162-6. PubMed ID: 10550055
[TBL] [Abstract][Full Text] [Related]
11. Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas.
Yoshikawa K; Ogawa T; Baer R; Hemmi H; Honda K; Yamauchi A; Inamoto T; Ko K; Yazumi S; Motoda H; Kodama H; Noguchi S; Gazdar AF; Yamaoka Y; Takahashi R
Int J Cancer; 2000 Oct; 88(1):28-36. PubMed ID: 10962436
[TBL] [Abstract][Full Text] [Related]
12. Effect of BRCA1 missense variants on gene reversion in DNA double-strand break repair mutants and cell cycle-arrested cells of Saccharomyces cerevisiae.
Lodovichi S; Bellè F; Cervelli T; Lorenzoni A; Maresca L; Cozzani C; Caligo MA; Galli A
Mutagenesis; 2020 Mar; 35(2):189-195. PubMed ID: 31769492
[TBL] [Abstract][Full Text] [Related]
13. Mutation screening of the MERIT40 gene encoding a novel BRCA1 and RAP80 interacting protein in breast cancer families.
Solyom S; Patterson-Fortin J; Pylkäs K; Greenberg RA; Winqvist R
Breast Cancer Res Treat; 2010 Feb; 120(1):165-8. PubMed ID: 19572197
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex.
Varma AK; Brown RS; Birrane G; Ladias JA
Biochemistry; 2005 Aug; 44(33):10941-6. PubMed ID: 16101277
[TBL] [Abstract][Full Text] [Related]
15. RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients.
Fan C; Zhang J; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
Int J Cancer; 2018 Oct; 143(8):1935-1942. PubMed ID: 29726012
[TBL] [Abstract][Full Text] [Related]
16. Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1.
Hernández G; Ramírez MJ; Minguillón J; Quiles P; Ruiz de Garibay G; Aza-Carmona M; Bogliolo M; Pujol R; Prados-Carvajal R; Fernández J; García N; López A; Gutiérrez-Enríquez S; Diez O; Benítez J; Salinas M; Teulé A; Brunet J; Radice P; Peterlongo P; Schindler D; Huertas P; Puente XS; Lázaro C; Pujana MÀ; Surrallés J
Nat Commun; 2018 Mar; 9(1):967. PubMed ID: 29511213
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer risk and the BRCA1 interacting protein CTIP.
Gorringe KL; Choong DY; Lindeman GJ; Visvader JE; Campbell IG
Breast Cancer Res Treat; 2008 Nov; 112(2):351-2. PubMed ID: 18095152
[TBL] [Abstract][Full Text] [Related]
18. The role of the BRCA1 tumor suppressor in DNA double-strand break repair.
Zhang J; Powell SN
Mol Cancer Res; 2005 Oct; 3(10):531-9. PubMed ID: 16254187
[TBL] [Abstract][Full Text] [Related]
19. Elevated radiation-induced γH2AX foci in G2 phase heterozygous BRCA2 fibroblasts.
Beucher A; Deckbar D; Schumann E; Krempler A; Frankenberg-Schwager M; Löbrich M
Radiother Oncol; 2011 Oct; 101(1):46-50. PubMed ID: 21665305
[TBL] [Abstract][Full Text] [Related]
20. Homologous repair of DNA damage and tumorigenesis: the BRCA connection.
Jasin M
Oncogene; 2002 Dec; 21(58):8981-93. PubMed ID: 12483514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
